Merck KGaA, Darmstadt, Germany: all 522 studies

Page 2 of 6. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)TerminatedNCT03387046Phase 2Results posted
• Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)CompletedNCT03369665Phase 4Results posted
• Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)CompletedNCT03364036Phase 4Results posted
• ATRi Transition Rollover StudyCompletedNCT03309150Phase 1Results posted
• First-in-Human Study of MS201408-0005A as Single Agent and in CombinationsTerminatedNCT03306420Phase 1Results posted
• First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy ParticipantsCompletedNCT03261401Phase 1Results posted
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid ArthritisCompletedNCT03233230Phase 2Results posted
• Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese ParticipantsCompletedNCT03226275Phase 1Results posted
• M3541 in Combination With Radiotherapy in Solid TumorsTerminatedNCT03225105Phase 1Results posted
• TICON-Day 3, Time Lapse Versus Conventional Method in Day 3 Embryo Culture and AssessmentTerminatedNCT03164551Phase 4Results posted
• M8891 First in Human in Solid TumorsTerminatedNCT03138538Phase 1Results posted
• Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure ParticipantsTerminatedNCT03026088Phase 4Results posted
• Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy VolunteersCompletedNCT03021642Phase 1Results posted
• Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) ParticipantsTerminatedNCT03010423Phase 4Results posted
• A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)TerminatedNCT02994953Phase 1Results posted
• A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple SclerosisTerminatedNCT02975349Phase 2Results posted
• A Phase II Study of M2951 in SLETerminatedNCT02975336Phase 2Results posted
• MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)TerminatedNCT02949908Results posted
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)Active, not recruitingNCT02864992Phase 2Results posted
• Efficacy and Safety of Atacicept in IgA NephropathyTerminatedNCT02808429Phase 2Results posted
• An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)CompletedNCT02806232Phase 2Results posted
• Safety and Efficacy Study of M2951 in Participants With Rheumatoid ArthritisCompletedNCT02784106Phase 2Results posted
• Abituzumab in SSc-ILDTerminatedNCT02745145Phase 2Results posted
• MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid TumorsCompletedNCT02699515Phase 1Results posted
• First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With ChemotherapyCompletedNCT02644278Phase 1Results posted
• Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)CompletedNCT02625623Phase 3Results posted
• Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)CompletedNCT02625610Phase 3Results posted
• Avelumab in First-line NSCLC (JAVELIN Lung 100)CompletedNCT02576574Phase 3Results posted
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid TumorsCompletedNCT02517398Phase 1Results posted
• Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With RadiotherapyCompletedNCT02516813Phase 1Results posted
• TiLE (Time Lapse Eeva) Clinical TrialCompletedNCT02417441Phase 4Results posted
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)CompletedNCT02395172Phase 3Results posted
• Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck CancerCompletedNCT02383966Phase 3Results posted
• Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy VolunteersCompletedNCT02325713Phase 1Results posted
• Bioequivalence Trial of Liquid Versus Freeze-Dried Pergoveris® in Pituitary Suppressed Healthy Premenopausal Female SubjectsCompletedNCT02317809Phase 1Results posted
• Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets (ODTs) of Praziquantel (PZQ) and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 YearsCompletedNCT02315352Phase 1Results posted
• First in Human Study of M4344 in Participants With Advanced Solid TumorsCompletedNCT02278250Phase 1Results posted
• Relative Bioavailability Trial of L-Praziquantel in Healthy VolunteersCompletedNCT02271984Phase 1Results posted
• A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue SarcomaTerminatedNCT02255110Phase 2Results posted
• Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™CompletedNCT02254304Phase 4Results posted
• Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 DiabetesCompletedNCT02252965Phase 4Results posted
• Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis SubjectsCompletedNCT02156466Phase 1Results posted
• Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)CompletedNCT02155647Phase 2Results posted
• RESOunD: REbif Satisfaction On Discontinuing Oral Dimethyl FumarateTerminatedNCT02117050Phase 4Results posted
• c-Met Second-Line Hepatocellular CarcinomaCompletedNCT02115373Phase 1/2Results posted
• Sym004 in Subjects With Stage IV Non-small Cell Lung CancerTerminatedNCT02083679Phase 1Results posted
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)TerminatedNCT02070978Phase 2Results posted
• A Study of Rebif® in Subjects With Relapsing Multiple SclerosisCompletedNCT02064816Phase 4Results posted
• Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung CancerTerminatedNCT02049151Phase 3Results posted
• Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)CompletedNCT02047227Phase 3Results posted
• Rebif® Rebidose® Versus Rebiject II® Ease-of-UseCompletedNCT02019550Phase 4Results posted
• Relative Bioavailability of Pimasertib in Cancer PatientsCompletedNCT01992874Phase 1Results posted
• Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular CarcinomaCompletedNCT01988493Phase 1/2Results posted
• Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)CompletedNCT01982955Phase 1/2Results posted
• Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of HypertensionCompletedNCT01977794Phase 3Results posted
• MSB0010445 and Stereotactic Body Radiation Therapy in Advanced MelanomaTerminatedNCT01973608Phase 2Results posted
• ATX-MS-1467 in Multiple SclerosisCompletedNCT01973491Phase 2Results posted
• Efficacy and Safety of Atacicept in Systemic Lupus ErythematosusCompletedNCT01972568Phase 2Results posted
• Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)TerminatedNCT01963611Phase 2Results posted
• Japanese Phase 1 Trial of Sym004 in Solid TumorsCompletedNCT01955473Phase 1Results posted
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN)CompletedNCT01943461Phase 1Results posted
• Trial of Pimasertib With SAR245409 or Placebo in Ovarian CancerCompletedNCT01936363Phase 2Results posted
• Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test KitCompletedNCT01921452Phase 4Results posted
• A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the KneeCompletedNCT01919164Phase 2Results posted
• Low-dose Gonal-f® in Ovulation InductionTerminatedNCT01871532Phase 4Results posted
• Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone GelCompletedNCT01863680Phase 3Results posted
• A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic CancerCompletedNCT01833546Phase 1Results posted
• A Japanese Phase 1 Trial of c-Met Inhibitor MSC2156119J in Subjects With Solid TumorsCompletedNCT01832506Phase 1Results posted
• An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)CompletedNCT01806298Phase 4Results posted
• A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ DeviceCompletedNCT01791244Phase 4Results posted
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)CompletedNCT01772004Phase 1Results posted
• A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)CompletedNCT01746862Phase 3Results posted
• Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Subjects With PhenylketonuriaCompletedNCT01732471Phase 3Results posted
• Oral Bioavailability and Mass Balance Trial With PimasertibCompletedNCT01713036Phase 1Results posted
• Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous MelanomaCompletedNCT01693068Phase 2Results posted
• A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the KneeTerminatedNCT01689337Phase 2Results posted
• A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as MonotherapyTerminatedNCT01668017Phase 1Results posted
• Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese WomenCompletedNCT01653743Phase 3Results posted
• Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1aCompletedNCT01514370Phase 2Results posted
• Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive PatientsCompletedNCT01508325Phase 4Results posted
• Tecemotide (L-BLP25) in Rectal CancerCompletedNCT01507103Phase 2Results posted
• A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive TechniqueTerminatedNCT01497197Phase 3Results posted
• Tecemotide (L-BLP25) in Prostate CancerCompletedNCT01496131Phase 2Results posted
• MSC2015103B in Solid TumorsTerminatedNCT01453387Phase 1Results posted
• Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) GenotypeCompletedNCT01450319Phase 2Results posted
• Common Safety Follow-up Trial of Tecemotide (L-BLP25)TerminatedNCT01423760Not applicableResults posted
• First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation StudyCompletedNCT01419249Phase 4Results posted
• A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)CompletedNCT01416987Results posted
• Saizen in Intra-uterine Growth RetardationCompletedNCT01400698Phase 3Results posted
• Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable AnginaCompletedNCT01396395Phase 4Results posted
• Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT01390818Phase 1Results posted
• Cetuximab in Combination With S-1 and Cisplatin in Gastric CancerCompletedNCT01388790Phase 2Results posted
• Combination Trial of Pimasertib (MSC1936369B) With TemsirolimusTerminatedNCT01378377Phase 1Results posted
• Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain ManagementCompletedNCT01364298Phase 4Results posted
• EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerCompletedNCT01360840Phase 2Results posted
• A Study of EMD525797 in Solid Tumor Patients in JapanCompletedNCT01327313Phase 1Results posted
• PERgoveriS In Stratified Treatment for Assisted Reproductive TechniqueCompletedNCT01297465Phase 3Results posted
• Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® TreatmentCompletedNCT01285401Phase 2Results posted
• Neuropathic Pain ManagementCompletedNCT01263132Phase 3Results posted
• A Randomized Controlled Study to Assess the Effects of Bisoprolol and Atenolol on Resting Heart Rate and Sympathetic Nervous System's Activity in Subjects With Essential HypertensionCompletedNCT01251146Phase 4Results posted

← Merck KGaA, Darmstadt, Germany overview and focus areas